Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.
about
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@en
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@nl
type
label
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@en
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@nl
prefLabel
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@en
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@nl
P2093
P2860
P1433
P1476
Adalimumab Reduces Extraintest ...... alysis of 11 Clinical Studies.
@en
P2093
Anne M Robinson
Anthony W Wang
Bidan Huang
Brandee Pappalardo
David A Schwartz
Edouard J Louis
Jen-Fue Maa
Robert Löfberg
Sofie Berg
Walter Reinisch
P2860
P2888
P304
P356
10.1007/S12325-018-0678-0
P407
P577
2018-03-07T00:00:00Z